Definitive Contract HT001419C0006
Award Date
8/29/19
Potential Completion Date
2/28/25
Potential Value
$386K
Federal Agency
Defense Health Agency
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The $165,700 contract has a performance period ending July 14, 2025 and is a call under a larger $828,750 single award blanket purchase agreement (BPA) from the VA's Veterans Integrated Service Network 1 for ClonoSEQ services benefiting VA medical...
The U.S. Defense Health Agency (DHA) has awarded a $76,200 firm fixed price purchase order to Adaptive Biotechnologies Corporation, doing business as Adaptive, for adaptive immunosequencing services. The award does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products. The company has previously received awards from the Department of Health and Human Services (HHS) and Department of Veterans Affairs (VA) to provide...
This is a $6,000 firm fixed price contract awarded by the Veterans Integrated Service Network 1 (VISN 1) of the Department of Veterans Affairs to Adaptive Biotechnologies Corporation, doing business as Adaptive, to provide ClonoSEQ minimal residual disease testing services. The contract is a call under a $828,750 single award blanket purchase agreement (BPA) with the VA's Veterans Health Administration, with two prior calls totaling $331,500 for ClonoSEQ services at VA medical facilities in...
This is a firm fixed price contract awarded by the Department of Veterans Affairs (VA) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The contract, with a ceiling value of $9,750.00, is a call under a $828,750.00 single award blanket purchase agreement held by Adaptive with the VA's Veterans Integrated Service Network 1 for a 5-year ordering period ending in July 2027. The contract supports VA medical facilities in the...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, to Adaptive Biotechnologies Corporation (also doing business as Adaptive) for IMMUNOSEQ MMTCRB SERVICE. The contract, valued at $12,200.00, does not have a set-aside designation. Through this award, Adaptive Biotechnologies will provide specialized sequencing and testing services to support HHS research programs. Adaptive...
This is a firm fixed price purchase order valued at $234,900.00 awarded by the National Institutes of Health (NIH) Clinical Center to Adaptive Biotechnologies Corporation, doing business as Adaptive, with a period of performance ending on September 30, 2024. The contract does not have a set-aside designation. Adaptive Biotechnologies is a commercial provider of immune-driven medicine services and products, including immunosequencing, DNA extraction, and COVID-19 research services for the...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) to Adaptive Biotechnologies Corporation, doing business as Adaptive, for ClonoSEQ minimal residual disease testing services. The $9,750 contract call has a performance period through July 2023 and is part of a larger $828,750 single award BPA for ClonoSEQ services benefiting VA medical facilities in the New England region. The BPA...
This firm fixed price contract, valued at $101,575.00, was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS), to Adaptive Biotechnologies Corporation. The contract is for Adaptive Biotechnologies to provide sequence-based detection of minimal residual disease (MRD) in acute lymphoblastic leukemia patients. The contract has a period of performance ending on September 20, 2018 and was awarded on September 21, 2016. Adaptive...
This federal contract award is for IMMUNOSEQ MMTCRB SERVICE (DEEP), catalog # ISS20001, with a quantity of 16, awarded to Adaptive Biotechnologies Corporation by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract has a firm fixed price of $16,560.00 and a completion date of July 31, 2025. This is not a set-aside contract. Adaptive Biotechnologies is a for-profit organization that specializes in...
This firm fixed-price federal contract award is for the provision of IMMUNOSEQ MMTCRB SEQUENCING SERVICE (DEEP) by Adaptive Biotechnologies Corporation, doing business as Adaptive, to the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The $10,400.00 contract has a completion date of July 3, 2024. Adaptive Biotechnologies is an established provider of immune-driven medicine services and products to federal...